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ABSTRACT
BACKGROUND: Uncontrolled cell proliferation and malignant transformation are the basic elements in
the development of malignant disease including cervical cancer and its precursors. The aim of this study
was to investigate the proliferative activity by using Ki-67 proliferative marker according to CIN grade. 
METHODS: We used immunohistochemical methods to study the expression of the proliferative marker
Ki-67 in the specimens of 5 patients with normal cervical epithelium, 7 with CIN1, 13 with CIN2, and 25
patients with CIN3 grade of the cervical intraepithelial lesions.
RESULTS: All cases with normal cervical epithelium and all those with CIN1 changes had negative pro-
liferative Ki-67 index. Ki-67 positive proliferative index was found in 5 (38.46%) and 17 (68%) of patients
with CIN2 and CIN3 changes respectively. There was a clear trend for increasing number of cases with
positive Ki-67 index with increasing CIN grade. High significant difference of Ki-67 expression was found
between patients with CIN1 and CIN2 lesions (t=2.9; p<0.01). Ki-67 positive cells were distributed only
in the lower third of the epithelial layer in CIN1 cases. Seven  (53.8%) and 13 (52%) of patients with
CIN2 and CIN3 changes respectively, had Ki-67 positive cells in the lower and middle third of the epithe-
lial layer, while 3 (23.1%) and 10 (40%) of cases with the same dysplastic changes had Ki-67 positive
cells distributed in lower, middle and upper third of the epithelium. Difference of the Ki-67 positive cells
distribution was highly significant between patient with CIN1 and CIN2 epithelial changes.
CONCLUSION: The present study shows that there is statistically significant relation between prolifera-
tive activity, distribution of Ki-67 positive cells, and CIN grade. Ki-67 antigen could be a tool to identify
women who are at higher risk for progression and/or recurrence of cervical squamous precancerous
lesions.
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INTRODUCTION 
U
ncontrolled cell proliferation and malignant transformation are the basic elements in the
development of cancer including cervical cancer and its precursors. Better understand-
ing of cell proliferation activity allows a more rational therapeutic approach (1). Loss of
genomic integrity is a defining feature of many human malignancies, including human papil-
loma virus associated preinvasive cervical intraepithelial neoplasms (CIN) and invasive cer-
vical squamous lesions (2,3). The centrosome is a cytoplasmic organelle consisting of a
pair of centrioles surrounded by a pericentriolar matrix. Each cell contains one or, before a
cell division, two centrosomes. During mitosis, the two centrosomes form the poles of a
bipolar mitotic spindle, a function that is essential for accurate chromosome segregation.
HPV E6 and E7 oncoproteins play distinct roles in this process by targeting different path-
ways. Whereas E6 may promote genetic instability by inactivating the tumor suppressor
protein p53, E7 subverts the integrity of the host cell genome by disregulation of Rb-E2F
complex and activation G1 to S-phase of cell cycle. E7 oncoprotein rapidly induces abnor-
mal centrosome duplication, whereas acute expression of HPV 16 E6 does not affect cen-
trosome number. Cells expressing both oncoproteins showed most pronounced alterations
of centrosome numbers, mitotic spindle poles and genomic integrity. High risk HPV E6 and 
E7 oncoproteins cooperate to induce centrosome-related mitotic aberrations resulting ane-
uploidy. In contrast, cells expressing low-risk HPV6 E6 and E7 proteins showed no such
abnormalities. Most cells with abnormal centrosomes are unable to complete mitosis. Small
number of cells progress through mitosis. Daughter cells derived abnormal mitoses are like-
ly to have acquired genomic changes (2-6).
The presence of abnormal mitotic figures (AMF), as well as polarity loss and cellular atyp-
ia are morphological  signs of cervical intraepithelial neoplasia. Different types of AMF have
been fond in those lesions including lag type mitoses, and their variants, multipolar mitoses
and the others. Strong association between the occurrence of leg type mitoses  and CIN
grade was found (7).
The aim of this study was to investigate the proliferative activity by using Ki-67 proliferativemarker, as well as distribution of Ki-67 positive cells through the epithelial layer according
to the CIN grade.
MATERIAL AND METHODS
Specimen of 45 cone biopsy were selected from the archives of the Department of
Pathology, Institute of Oncology, Sremska Kamenica. Those cases were classified as CIN1
(n=7), CIN2 (n=13), CIN3 (n=25).
The tissue had been fixed in buffered 4% formaldehyde, embedded in paraffin, cut at 4 ￿,
and stained with hematoxylin and eosin (HE). Paraffin sections of 4 ￿ thickness adjacent
to the HE sections  used for CIN grade assessment, were mounted onto Super Frost Plus
Slides and dried overnight at 37…C. The streptavidin-biotin peroxidase complex meted was
used for immunohistochemistry. Briefly, sections were dewaxed, and hydrated through
graded alcohols to water. 
Immunostaining for Ki-67 (DAKO Glostrup, Denmark) was carried out. Following  endoge-
nous peroxide and protein blocking step, the slides were incubated with primary antibod-
ies. After brief washes, incubation in a cocktail of biotinylated rabbit anti-mouse IgG/IgM for
30 min was performed. 
The sections were then washed and incubated with streptavidin-biotinylated horseradish
peroxidase complex for 30 min, reacted with 3-amino-9-ethylcabazole (AEC, DAKO) and
hydrogen peroxide. To  visualize the end product hematoxylin was used as counter stain.
Sections stained for Ki-67 were assigned scores of 0-3, with 0 meaning no staining; 1,
weak positive, the mounts of positive cells are less than 10%; 2, positive, the mounts of
positive cells are more than 10% but less than 50%; and 3, strong positive, the mounts of
positive cells are more than 50%. Scores 0 and 1 were counted as negative and scores 2
and 3 as positive cases (8).  Nuclear staining  was evaluated. 
To investigate significant differences between the three CIN grades, Student test was per-
formed. 
c2 test was used to calculate the topography differences of Ki-67 expression between CIN
grades. The level of significance was set to p<0.05.
RESULTS
The mean age of all patients was 36.4–5.53 years. The mean age of patients with dys-
plastic epithelial changes grade CIN1, CIN2 and CIN3 were 36.7–7, 36.8–7 and 36.2–5
years respectively. There was no statistical significance between grade of CIN changes and
patient age. Immunoreactive Ki-67 positive cells showed dark brown, homogenous or
punctate staining, limited exclusively to the nucleus (Figure 1).
All cases with CIN1 changes had negative proliferative Ki-67 index. Ki-67 positive prolifer-
ative index was found in 5 (38.46%) and 17 (68%) of patients with CIN2 and CIN3 changes
respectively (Figure 2). There was a clear trend for increasing number of cases with posi-
tive Ki-67 index with increasing CIN grade, although no significant difference was found
between cases with CIN2 and CIN3 changes (t=1.9; p>0.05). High significant difference
was found between patients with CIN1 and CIN2 lesions (t=2.9; p<0.01).
We also investigate distribution of Ki-67 positive nuclei through the cervical epithelial layer
(Figure 3). Ki-67 positive cells were distributed only in the lower third of the epithelial layer
in CIN1 cases. 7 (53.8%) and 13 (52%) of patients with CIN2 and CIN3 changes respec-
tively, had Ki-67 positive cells in the lower and middle third of the epithelial layer, while 3
(23.1%) and 10 (40%) of cases with the same dysplastic changes had Ki-67 positive cells
distributed in lower, middle and upper third of the epithelium. No significant difference was
found in the distribution of Ki-67 positive cells between CIN2 and CIN3 cases (c2=2.91),
while that difference was highly significant between patient with CIN1 and CIN2 epithelial
changes (c2=9.04, p<0.005). 
DISCUSSION
Cell proliferation can be followed  up by the expression of some cell proteins such as PCNA
and Ki-67 antigen. Ki-67 is a nuclear antigen expressed during G1, S, M and G2 periods of
cell cycle. The expression level of Ki-67 indicated the status of cell proliferation. Some stud-
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Figure 1. Expression of the Ki-67 antigen in the dysplastic cervical epithelium, x200
Figure 2. Ki-67 expression according to the CIN grade
Figure 3. Distribution of the Ki-67 positive cells through dysplastic cervical epitheliumies have showed that Ki-67 protein could be a biomarker in the evaluation of the prolifera-
tive activity and progressive potential of normal, dysplastic and neoplastic changes (9,10).
Our results showed that there was significant relation between the proliferative Ki-67 activ-
ity and CIN grade. Statistical difference between CIN1 and CIN2 group was significant, while
no significant difference between CIN2 and CIN3 group of cases was found. We have also
found differences of the Ki-67 positive cell distribution according to the CIN grade. There
was a clear trend for increasing number of cases with Ki-67 positive cells in the middle and
upper third  of the epithelial layer with increasing CIN grade, although there was statistical-
ly significant difference only between CIN1 and CIN2 grade. Cases with CIN2 and CIN3
lesions showed considerable overlap. 
Kruse et al. (10) have found that there was a significant relation  between CIN grade and
number of Ki-67 positive cells by using QPRODIT image analyzing system. The distribution
of Ki-67 positive cells was related with CIN grade but  there was overlap between CIN2 and
CIN3 lesions like in our study.
The therapeutic significance  of the distinction between CIN2 and CIN3 varies in different
centers and can be important. It may thus be that CIN2 cases consist of two biologically
different subgroups, which makes it tempting to speculate that this difference is due to the
absence or presence of oncogenic human papilloma virus (10).
Tjalma’s et al. (1) results have shown the presence of link between the increase in prolifer-
ative activity in CIN3 lesions, expressed as PCNA immunoreactivity and a risk of recurrence,
and the great heterogeneity of PCNA expression in CIN3 lesions. CIN3 lesions with high pro-
liferative activity are probably at higher risk to undergo genetic changes that may lead to
recurrent CIN or invasive disease.
The results of al-Saleh’s (11) study were similar. They also have found that HPV 16/18 cer-
vical epithelial changes were significantly associated with higher densities of Ki-67 positive
cells than HPV 6/11 positive type of cervical lesions. Similar changes were found in pre-
cancerous esophageal lesions (8).
Sahebali et al. (12) performed Ki-67 immunostaining in cervical cytology samples. There
were a significantly higher number of immunopositive cells in high-grade squamous
intraepithelial lesions as well as in HPV16 positive samples.  The infection of cervical cells
by HPV manifests itself by changes in the function or expression of the host genes, and the
detection of these alterations can play a role in diagnosis. These changes cause disregula-
tion of the cell cycle, manifested by abnormal proteins such as Ki-67. The detection of
abnormal expression can identify clinical important cases of HPV infection with risk of pro-
gression towards dysplasia and carcinoma (12).
Ki-67 proliferative marker is very important  for predict the value for progression of CIN1
and CIN2 lesions but according to recent studies it is not enough. Kruse et al. showed that
other markers are also important such as Rb-positive nuclei in the deeper half of the epithe-
lium and the proportions of CK13 and CK14-positive cells (4). Expression of p16 is also an
important prognostic factor, which is connected with the expression of Rb-E2F complex and
influence of E7 oncoprotein on it (4-6).
CONCLUSION
Although the present study shows that there is statistically significant positive relation
between proliferative activity, distribution of Ki-67 positive cells and increasing CIN grade,
it is based on statistics of a small number of cases so further investigations are needed.
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